.png)
Unify Through Awareness
Financial Services
Case Background
A global healthcare company was preparing to launch a groundbreaking drug in the US market for a complex and highly fragmented rare disease. Recognizing the unique challenges and opportunities presented by this ambitious endeavor, our team was engaged to devise innovative solutions that would ensure a successful launch. Our primary objective was to identify and implement top tactics and proven successes from both within and beyond the healthcare industry. This would not only maximize awareness of Product X but also unify the diverse ecosystem involved in treating the rare disease. We aimed to create a cohesive strategy that leveraged cross-industry insights, tailored communication plans, and strategic partnerships to position Product X as a transformative treatment option.
We applied our proven strategic innovation approach, which consists of three critical phases: FRAME, CREATE, and PRIME. During the FRAME phase, we meticulously identified the core challenges associated with Disease X. This process involved an extensive market research deep dive, where we analyzed current trends, market dynamics, and patient needs. Additionally, we conducted key discussions with the project team to gain a comprehensive understanding of the disease's intricacies. The insights gathered during the FRAME phase were instrumental in guiding our search for best practices from other diseases facing similar challenges. We identified over 25 diseases that matched our search criteria, each presenting unique strategies and solutions that could potentially be adapted for Disease X. These diseases were then carefully filtered using specific parameters relevant to Disease X. This filtering process ensured that we focused only on the most applicable and impactful strategies. The refined list of diseases provided a rich repository of best practices and innovative solutions. By analyzing and benchmarking these strategies, we could draw parallels and identify actionable insights tailored to the unique challenges of Disease X. This approach enabled us to develop a robust framework for the subsequent PRIME phase, setting a solid foundation for crafting and executing a successful launch strategy for the new drug.
Our Approach
The final output revealed four disease states most similar to Disease X, uncovering four winning themes: strategic collaborations, passionate leaders, rallying points, and community empowerment. Seeking further inspiration, we assessed over 35 precedents outside of pharma, with four providing the most relevant insights for Disease X’s situation: unifying a community, building trust within the community, fighting for a cause, and shifting mindsets. These winning themes from both within and outside the pharmaceutical industry helped shape the strategic imperatives for maximizing awareness and unifying the ecosystem during the final phase of the project, PRIME.
Output
Unify Through Awareness
Financial Services
Case Background
A global healthcare company was preparing to launch a groundbreaking drug in the US market for a complex and highly fragmented rare disease. Recognizing the unique challenges and opportunities presented by this ambitious endeavor, our team was engaged to devise innovative solutions that would ensure a successful launch. Our primary objective was to identify and implement top tactics and proven successes from both within and beyond the healthcare industry. This would not only maximize awareness of Product X but also unify the diverse ecosystem involved in treating the rare disease. We aimed to create a cohesive strategy that leveraged cross-industry insights, tailored communication plans, and strategic partnerships to position Product X as a transformative treatment option.
We applied our proven strategic innovation approach, which consists of three critical phases: FRAME, CREATE, and PRIME. During the FRAME phase, we meticulously identified the core challenges associated with Disease X. This process involved an extensive market research deep dive, where we analyzed current trends, market dynamics, and patient needs. Additionally, we conducted key discussions with the project team to gain a comprehensive understanding of the disease's intricacies. The insights gathered during the FRAME phase were instrumental in guiding our search for best practices from other diseases facing similar challenges. We identified over 25 diseases that matched our search criteria, each presenting unique strategies and solutions that could potentially be adapted for Disease X. These diseases were then carefully filtered using specific parameters relevant to Disease X. This filtering process ensured that we focused only on the most applicable and impactful strategies. The refined list of diseases provided a rich repository of best practices and innovative solutions. By analyzing and benchmarking these strategies, we could draw parallels and identify actionable insights tailored to the unique challenges of Disease X. This approach enabled us to develop a robust framework for the subsequent PRIME phase, setting a solid foundation for crafting and executing a successful launch strategy for the new drug.
Our Approach
The final output revealed four disease states most similar to Disease X, uncovering four winning themes: strategic collaborations, passionate leaders, rallying points, and community empowerment. Seeking further inspiration, we assessed over 35 precedents outside of pharma, with four providing the most relevant insights for Disease X’s situation: unifying a community, building trust within the community, fighting for a cause, and shifting mindsets. These winning themes from both within and outside the pharmaceutical industry helped shape the strategic imperatives for maximizing awareness and unifying the ecosystem during the final phase of the project, PRIME.